Xilio Therapeutics, Inc. - COM (XLO)

Historical Portfolio Holders from Q4 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
13M
Holdings value Q2 2024
$12.3M
Value change Q2 2024
+$1.79M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
30
Number of buys Q2 2024
16
Number of sells Q2 2024
-11
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 13M $12.3M +$1.79M $0.95 30
2024 Q1 11M $11.9M -$2.68M $1.08 28
2023 Q4 15M $8.22M -$1.54M $0.55 32
2023 Q3 15.9M $33.5M -$315K $2.11 30
2023 Q2 16M $41.9M -$192K $2.62 32
2023 Q1 16.1M $51M +$462K $3.17 32
2022 Q4 15.9M $42.8M -$711K $2.69 28
2022 Q3 16.6M $48.3M -$3.74M $2.91 27
2022 Q2 17.9M $52.2M -$3.66M $2.92 27
2022 Q1 18.8M $133M -$2.58M $7.07 41
2021 Q4 19M $303M +$259M $16.00 41